These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
473 related items for PubMed ID: 7773481
1. Influence of local treatment on the recurrence rate of ductal carcinoma in situ. Warneke J, Grossklaus D, Davis J, Stea B, Bebb G, Taylor C, Hastings R, Villar H. J Am Coll Surg; 1995 Jun; 180(6):683-8. PubMed ID: 7773481 [Abstract] [Full Text] [Related]
2. 259 Patients with DCIS of the breast applying USC/Van Nuys prognostic index: a retrospective review with long term follow up. Di Saverio S, Catena F, Santini D, Ansaloni L, Fogacci T, Mignani S, Leone A, Gazzotti F, Gagliardi S, De Cataldis A, Taffurelli M. Breast Cancer Res Treat; 2008 Jun; 109(3):405-16. PubMed ID: 17687650 [Abstract] [Full Text] [Related]
3. Local recurrence after conservative surgery and radiation therapy for ductal carcinoma in situ: Possible importance of family history. Hiramatsu H, Bornstein BA, Recht A, Schnitt SJ, Baum JK, Connolly JL, Duda RB, Guidi AJ, Kaelin CM, Silver EB, Harris JR. Cancer J Sci Am; 1995 Jun; 1(1):55-61. PubMed ID: 9166455 [Abstract] [Full Text] [Related]
4. Outcomes and factors impacting local recurrence of ductal carcinoma in situ. Weng EY, Juillard GJ, Parker RG, Chang HR, Gornbein JA. Cancer; 2000 Apr 01; 88(7):1643-9. PubMed ID: 10738223 [Abstract] [Full Text] [Related]
5. Ductal carcinoma in situ (DCIS) of the breast: evolving perspectives. Sakorafas GH, Tsiotou AG. Cancer Treat Rev; 2000 Apr 01; 26(2):103-25. PubMed ID: 10772968 [Abstract] [Full Text] [Related]
6. Mammographically detected, clinically occult ductal carcinoma in situ treated with breast-conserving surgery and definitive breast irradiation. Solin LJ, McCormick B, Recht A, Haffty BG, Taylor ME, Kuske RR, Bornstein BA, McNeese M, Schultz DJ, Fowble BL, Barrett W, Yeh IT, Kurtz JM, Amalric R, Fourquet A. Cancer J Sci Am; 1996 Apr 01; 2(3):158-65. PubMed ID: 9166516 [Abstract] [Full Text] [Related]
7. The management of ductal carcinoma in situ (DCIS). The Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer. Canadian Association of Radiation Oncologists. CMAJ; 1998 Feb 10; 158 Suppl 3():S27-34. PubMed ID: 9484276 [Abstract] [Full Text] [Related]
8. Predictors of local recurrence after treatment of ductal carcinoma in situ: a meta-analysis. Boyages J, Delaney G, Taylor R. Cancer; 1999 Feb 01; 85(3):616-28. PubMed ID: 10091735 [Abstract] [Full Text] [Related]
9. Optimal management of ductal carcinoma in situ of the breast. Sakorafas GH, Farley DR. Surg Oncol; 2003 Dec 01; 12(4):221-40. PubMed ID: 14998563 [Abstract] [Full Text] [Related]
10. Preliminary results and evaluation of MammoSite balloon brachytherapy for partial breast irradiation for pure ductal carcinoma in situ: a phase II clinical study. Benitez PR, Streeter O, Vicini F, Mehta V, Quiet C, Kuske R, Hayes MK, Arthur D, Kuerer H, Freedman G, Keisch M, Dipetrillo T, Khan D, Hudes R. Am J Surg; 2006 Oct 01; 192(4):427-33. PubMed ID: 16978943 [Abstract] [Full Text] [Related]
11. Microinvasive breast carcinoma: clinicopathologic analysis of a single institution experience. Padmore RF, Fowble B, Hoffman J, Rosser C, Hanlon A, Patchefsky AS. Cancer; 2000 Mar 15; 88(6):1403-9. PubMed ID: 10717623 [Abstract] [Full Text] [Related]
12. Salvage treatment for local recurrence after breast-conserving surgery and radiation as initial treatment for mammographically detected ductal carcinoma in situ of the breast. Solin LJ, Fourquet A, Vicini FA, Haffty B, Taylor M, McCormick B, McNeese M, Pierce LJ, Landmann C, Olivotto IA, Borger J, de La Rochefordiere A, Schultz DJ. Cancer; 2001 Mar 15; 91(6):1090-7. PubMed ID: 11267953 [Abstract] [Full Text] [Related]
13. Predictors of local recurrence following excision alone for ductal carcinoma in situ. Hetelekidis S, Collins L, Silver B, Manola J, Gelman R, Cooper A, Lester S, Lyons JA, Harris JR, Schnitt SJ. Cancer; 1999 Jan 15; 85(2):427-31. PubMed ID: 10023711 [Abstract] [Full Text] [Related]
14. Factors associated with local recurrence and cause-specific survival in patients with ductal carcinoma in situ of the breast treated with breast-conserving therapy or mastectomy. Vargas C, Kestin L, Go N, Krauss D, Chen P, Goldstein N, Martinez A, Vicini FA. Int J Radiat Oncol Biol Phys; 2005 Dec 01; 63(5):1514-21. PubMed ID: 16005576 [Abstract] [Full Text] [Related]
15. Radiation treatment for ductal carcinoma in situ (DCIS): is a boost to the tumor bed necessary? Yerushalmi R, Sulkes A, Mishaeli M, Neumann A, Dinerman M, Sulkes J, Rizel S, Yarom N, Gutman H, Fenig E. Neoplasma; 2006 Dec 01; 53(6):507-10. PubMed ID: 17167720 [Abstract] [Full Text] [Related]
16. Clinical outcome after selective treatment of patients diagnosed with ductal carcinoma in situ of the breast. Meijnen P, Oldenburg HS, Peterse JL, Bartelink H, Rutgers EJ. Ann Surg Oncol; 2008 Jan 01; 15(1):235-43. PubMed ID: 17987342 [Abstract] [Full Text] [Related]
19. Defining negative margins in DCIS patients treated with breast conservation therapy: The University of Chicago experience. Sahoo S, Recant WM, Jaskowiak N, Tong L, Heimann R. Breast J; 2005 Jan 01; 11(4):242-7. PubMed ID: 15982389 [Abstract] [Full Text] [Related]
20. Local recurrences after different treatment strategies for ductal carcinoma in situ of the breast: a population-based study in the East Netherlands. Schouten van der Velden AP, van Vugt R, Van Dijck JA, Leer JW, Wobbes T. Int J Radiat Oncol Biol Phys; 2007 Nov 01; 69(3):703-10. PubMed ID: 17544591 [Abstract] [Full Text] [Related] Page: [Next] [New Search]